Literature DB >> 7956945

Functional and morphological characterization of four cell lines derived from GH3 cells stably transfected with gonadotropin-releasing hormone receptor complementary deoxyribonucleic acid.

D Stanislaus1, J A Janovick, L Jennes, U B Kaiser, W W Chin, P M Conn.   

Abstract

Four cell lines, stably transfected with rat GnRH receptor complementary DNA, have been prepared from the lactotropic GH3 cell line. All four lines (as well as the parent line and a line transfected with the vector DNA) show extensive rosettes of circular polyribosomes, characteristic of high protein synthetic activity, although secretory granules are virtually absent; the rough endoplasmic reticulum (rER) cisternae were short and straight. Instances were observed in which the ER reaches to the plasma membrane, suggesting a possible nongranular secretory route. All four lines (but not the parent or a control transfected line) expressed GnRH receptors that were down-regulated (1-5 h, depending on the cell line) after exposure to 10 nM GnRH; receptors then recovered (2-7 h). This pattern is reminiscent of the GnRH receptor in the primary gonadotrope cell cultures. All cell lines released PRL (4-96 h) in response to a GnRH agonist (D-tBuSer6-des-Gly10-Pro9-ethylamide-GnRH), an event that was inhibited by all three major classes of Ca+2 ion channel antagonists (methoxyverapamil, 1,4-dihydropyridines, and diltiazem); in contrast, GnRH-stimulated LH release from pituitary-derived primary cultures is only inhibited by methoxyverapamil. One line became refractory to GnRH analog stimulation after 24 h, although the other three released PRL vigorously up to the longest time point examined (96 h). All four lines responded substantially more robustly to 1 microgram/ml Buserelin than to 1 microgram/ml TRH. All four lines produced inositol phosphate metabolites and released immunoassayable cAMP (24 h) in response to treatment with Buserelin. These cell lines are good models for understanding the mechanisms by which the GnRH receptor is coupled to second messenger systems and for comparing these mechanisms with TRH-receptor coupling in the same cell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956945     DOI: 10.1210/endo.135.5.7956945

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment.

Authors:  Timothy P Brown; Pushpak Bhattacharjee; Sabarish Ramachandran; Sathish Sivaprakasam; Bojana Ristic; Mohd Omar F Sikder; Vadivel Ganapathy
Journal:  Oncogene       Date:  2020-02-19       Impact factor: 9.867

2.  Gonadotropin-releasing hormone receptor concentration differentially regulates intracellular signaling pathways in GGH3 cells.

Authors:  J H Pinter; J A Janovick; P M Conn
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

3.  Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas.

Authors:  A Lania; G Mantovani; E Ferrante; L M Zavanone; M Locatelli; S Corbetta; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

4.  Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine.

Authors:  Jo Ann Janovick; Guadalupe Maya-Núñez; Alfredo Ulloa-Aguirre; Ilpo T Huhtaniemi; James A Dias; Pieter Verbost; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2008-09-20       Impact factor: 4.102

5.  A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone.

Authors:  U B Kaiser; E Sabbagh; R A Katzenellenbogen; P M Conn; W W Chin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

6.  Mechanisms underlying the tissue-specific and regulated activity of the Gnrhr promoter in mammals.

Authors:  Anne-Laure Schang; Bruno Quérat; Violaine Simon; Ghislaine Garrel; Christian Bleux; Raymond Counis; Joëlle Cohen-Tannoudji; Jean-Noël Laverrière
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-13       Impact factor: 5.555

7.  Pharmacoperone rescue of vasopressin 2 receptor mutants reveals unexpected constitutive activity and coupling bias.

Authors:  Jo Ann Janovick; Timothy P Spicer; Thomas D Bannister; Louis Scampavia; P Michael Conn
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.